课题基金 / 基金详情

Pseudomonas aeruginosa infection: analysis of antigenic proteins of the virulence-associated type VI secretion system

Pseudomonas aeruginosa infection: analysis of antigenic proteins of the virulence-associated type VI secretion system
铜绿假单胞菌感染:毒力相关 VI 型分泌系统抗原蛋白分析
批准号:
G0800171/1
负责人:
Alain Filloux
金额:
$67.21万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Alain Filloux的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Interaction between microbes and human hosts can range from a benign, even commensal collaboration to a competition that may turn fatal resulting in the death of the host, the bacteria or both. The outcome of the interaction is balanced by a communication/signalling game in between the host and the pathogen. Among the arsenal of communication tools used by bacteria to influence host response are secretion systems (SS), which deliver toxins to the host. The SS and the transported toxins are key players in bacterial pathogenesis. Recent studies have seen the emergence of a novel type of SS, named T6SS. Bacteria harbouring T6SS all have a life style where they live in intimate contact with a host.Pseudomonas aeruginosa is an opportunistic pathogen. It causes urinary tract infections, respiratory system infections, dermatitis, soft tissue infections, bacteremia, bone and joint infections, gastrointestinal infections and a variety of systemic infections, particularly in immuno-suppressed patients. P. aeruginosa infection is a serious problem in patients hospitalized with cancer, cystic fibrosis, and burns. The case fatality rate in these patients is 50 percent. P. aeruginosa is the third most commonly-isolated nosocomial pathogen accounting for 10% of all hospital-acquired infections.P. aeruginosa possesses 3 T6SS. The goal of our study is to understand the molecular mechanisms, which are involved in the T6SS functioning, knowledge applicable to other T6SS-containing bacterial pathogens. We will further use this knowledge to develop antimicrobials, which will help fighting human morbidity and mortality due to persistent bacterial infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The T6SS as a search engine for naturally validated antibacterial targets
  • 批准号:
    MR/S02316X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $67.78万
  • 财政年份:
    2019
  • 负责人:
    Alain Filloux
  • 依托单位:
A bacterial c-di-GMP responsive enzyme modulates LPS structure and triggers immune evasion
  • 批准号:
    BB/R00174X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $61.98万
  • 财政年份:
    2018
  • 负责人:
    Alain Filloux
  • 依托单位:
Type VI secretion in Pseudomonas species: bacterial competition and biocontrol
  • 批准号:
    BB/N002539/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $55.44万
  • 财政年份:
    2016
  • 负责人:
    Alain Filloux
  • 依托单位:
The T6SS toxins are powerful weapons for Pseudomonas' antibacterial strategy
  • 批准号:
    MR/N023250/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $58.04万
  • 财政年份:
    2016
  • 负责人:
    Alain Filloux
  • 依托单位:
国内基金
海外基金
基于多组学技术探究新加达原散通过调控双组分系统影响耐药P.Aeruginosa生物膜的机制研究
  • 批准号:
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    齐文升
  • 依托单位:
生物质炭负载噬菌体对土壤中抗生素耐药菌(Pseudomonas aeruginosa)迁移阻控及靶向裂解的协同机制
  • 批准号:
    42077106
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2020
  • 负责人:
    孙明明
  • 依托单位:
P.aeruginosa感染创面中EZH2和MLL1介导组蛋白甲基化对ECM重塑的作用机制研究
  • 批准号:
    81971842
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    张连波
  • 依托单位:
绿脓杆菌 (P. aeruginosa) 影响呼吸道上皮细胞层功能的机制研究
  • 批准号:
    81570001
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2015
  • 负责人:
    陈正豪
  • 依托单位: